Literature DB >> 27056984

Prevalence of Intracranial Atherosclerotic Stenosis Using High-Resolution Magnetic Resonance Angiography in the General Population: The Atherosclerosis Risk in Communities Study.

Muhammad Fareed K Suri1, Ye Qiao2, Xiaoye Ma2, Eliseo Guallar2, Jincheng Zhou2, Yiyi Zhang2, Li Liu2, Haitao Chu2, Adnan I Qureshi2, Alvaro Alonso2, Aaron R Folsom2, Bruce A Wasserman2.   

Abstract

BACKGROUND AND
PURPOSE: Intracranial atherosclerotic stenosis (ICAS) is a common cause of stroke, but little is known about its epidemiology. We studied the prevalence of ICAS and its association with vascular risk factors using high-resolution magnetic resonance angiography in a US cardiovascular cohort.
METHODS: The Atherosclerosis Risk in Communities (ARIC) study recruited participants from 4 US communities from 1987 to 1989. Using stratified sampling, we selected 1980 participants from visit 5 (2011-2013) for high-resolution 3T-magnetic resonance angiography. All images were analyzed in a centralized laboratory, and ICAS was graded as: no stenosis, <50% stenosis, 50% to 69% stenosis, 70% to 99% stenosis, and complete occlusion. We calculated per-vessel and per-person prevalence of ICAS (weighted for n=6538 visit 5 participants) and also estimated the US prevalence. We used multivariable logistic regression to identify variables independently associated with ICAS.
RESULTS: Subjects who had an adequate magnetic resonance angiography (n=1765) were aged 67 to 90 years, 41% were men, 70% were white, and 29% were black. ICAS was prevalent in 31% of participants and 9% had ICAS ≥50%. Estimated US prevalence of ICAS ≥50% for 65 to 90 years old was 8% for whites and 12% for blacks. Older age, black race, higher systolic blood pressure, and higher low-density lipoprotein cholesterol levels were associated with increased odds of ICAS, whereas higher levels of high-density lipoprotein cholesterol and use of cholesterol-lowering medications were associated with decreased odds of ICAS. Body mass index and smoking were not associated with ICAS.
CONCLUSIONS: The prevalence of ICAS in older adults is high, and it could be a target for primary prevention of stroke and dementia in this population.
© 2016 American Heart Association, Inc.

Entities:  

Keywords:  intracranial atherosclerosis stenosis; intracranial stenosis; magnetic resonance angiography; prevalence

Mesh:

Year:  2016        PMID: 27056984      PMCID: PMC5319392          DOI: 10.1161/STROKEAHA.115.011292

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  34 in total

Review 1.  Race, sex and occlusive cerebrovascular disease: a review.

Authors:  L R Caplan; P B Gorelick; D B Hier
Journal:  Stroke       Date:  1986 Jul-Aug       Impact factor: 7.914

Review 2.  Intracranial atherosclerosis.

Authors:  Adnan I Qureshi; Louis R Caplan
Journal:  Lancet       Date:  2013-09-02       Impact factor: 79.321

3.  The Stroke Outcomes and Neuroimaging of Intracranial Atherosclerosis (SONIA) trial.

Authors:  E Feldmann; J L Wilterdink; A Kosinski; M Lynn; M I Chimowitz; J Sarafin; H H Smith; F Nichols; J Rogg; H J Cloft; L Wechsler; J Saver; S R Levine; C Tegeler; R Adams; M Sloan
Journal:  Neurology       Date:  2007-04-04       Impact factor: 9.910

4.  Detection of intracranial atherosclerotic steno-occlusive disease with 3D time-of-flight magnetic resonance angiography with sensitivity encoding at 3T.

Authors:  C G Choi; D H Lee; J H Lee; H W Pyun; D W Kang; S U Kwon; J K Kim; S J Kim; D C Suh
Journal:  AJNR Am J Neuroradiol       Date:  2007-03       Impact factor: 3.825

5.  The prevalence of asymptomatic intracranial large-vessel occlusive disease: the role of diabetes.

Authors:  Erin M Elmore; Aurelio Mosquera; Jesse Weinberger
Journal:  J Neuroimaging       Date:  2003-07       Impact factor: 2.486

6.  Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial.

Authors:  Steven E Nissen; E Murat Tuzcu; Paul Schoenhagen; B Greg Brown; Peter Ganz; Robert A Vogel; Tim Crowe; Gail Howard; Christopher J Cooper; Bruce Brodie; Cindy L Grines; Anthony N DeMaria
Journal:  JAMA       Date:  2004-03-03       Impact factor: 56.272

7.  Race-ethnicity and determinants of intracranial atherosclerotic cerebral infarction. The Northern Manhattan Stroke Study.

Authors:  R L Sacco; D E Kargman; Q Gu; M C Zamanillo
Journal:  Stroke       Date:  1995-01       Impact factor: 7.914

8.  Racial differences in vascular risk factors and outcomes of patients with intracranial atherosclerotic arterial stenosis.

Authors:  Salina P Waddy; George Cotsonis; Michael J Lynn; Michael R Frankel; Seemant Chaturvedi; Janice E Williams; Marc Chimowitz
Journal:  Stroke       Date:  2008-10-02       Impact factor: 7.914

9.  Prevalence and risk factors of middle cerebral artery stenosis in asymptomatic residents in Rongqi County, Guangdong.

Authors:  Hai Wei Huang; Ming Hui Guo; Rui Jin Lin; Ya Li Chen; Qin Luo; Ying Zhang; Ka Sing Wong
Journal:  Cerebrovasc Dis       Date:  2007-05-23       Impact factor: 2.762

10.  Current cigarette smoking among adults - United States, 2011.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2012-11-09       Impact factor: 17.586

View more
  33 in total

Review 1.  Cerebral Vascular Disease and Neurovascular Injury in Ischemic Stroke.

Authors:  Xiaoming Hu; T Michael De Silva; Jun Chen; Frank M Faraci
Journal:  Circ Res       Date:  2017-02-03       Impact factor: 17.367

2.  Intracranial Atherosclerosis: A Disease of Functional, not Anatomic Stenosis? How Trans-Stenotic Pressure Gradients Can Help Guide Treatment.

Authors:  Mario Zanaty; James D Rossen; Jorge A Roa; Daichi Nakagawa; Joseph S Hudson; Sami Al Kasab; Kaustubh Limaye; Khaled Asi; Sudeepta Dandapat; Pascal Jabbour; Edgar A Samaniego; David M Hasan
Journal:  Oper Neurosurg (Hagerstown)       Date:  2020-06-01       Impact factor: 2.703

3.  Metabolic syndrome is associated with increased risk of short-term post-procedural complications after carotid artery stenting.

Authors:  Shuyang Dong; Zeyan Peng; Yong Tao; Yinchao Huo; Huadong Zhou
Journal:  Neurol Sci       Date:  2017-08-07       Impact factor: 3.307

4.  Intracranial Atherosclerotic Burden on 7T MRI Is Associated with Markers of Extracranial Atherosclerosis: The SMART-MR Study.

Authors:  M H T Zwartbol; M I Geerlings; R Ghaznawi; J Hendrikse; A G van der Kolk
Journal:  AJNR Am J Neuroradiol       Date:  2019-12-05       Impact factor: 3.825

5.  Racial Differences in Prevalence and Risk for Intracranial Atherosclerosis in a US Community-Based Population.

Authors:  Ye Qiao; Fareed K Suri; Yiyi Zhang; Li Liu; Rebecca Gottesman; Alvaro Alonso; Eliseo Guallar; Bruce A Wasserman
Journal:  JAMA Cardiol       Date:  2017-12-01       Impact factor: 14.676

Review 6.  Pathogenic mechanisms following ischemic stroke.

Authors:  Seyed Esmaeil Khoshnam; William Winlow; Maryam Farzaneh; Yaghoob Farbood; Hadi Fathi Moghaddam
Journal:  Neurol Sci       Date:  2017-04-17       Impact factor: 3.307

7.  Quantifying Intracranial Internal Carotid Artery Stenosis on MR Angiography.

Authors:  H Baradaran; P Patel; G Gialdini; K Al-Dasuqi; A Giambrone; H Kamel; A Gupta
Journal:  AJNR Am J Neuroradiol       Date:  2017-03-16       Impact factor: 3.825

8.  Association between excessive supraventricular ectopy and subclinical cerebrovascular disease: a population-based study.

Authors:  T Hisamatsu; K Miura; A Fujiyoshi; A Kunimura; T Ito; I Miyazawa; S Torii; A Shiino; K Nozaki; H Kanda; H Arima; T Ohkubo; H Ueshima
Journal:  Eur J Neurol       Date:  2019-05-09       Impact factor: 6.089

9.  Association between serum bilirubin and asymptomatic intracranial atherosclerosis: results from a population-based study.

Authors:  Kaiyi Zhong; Xiang Wang; Xiaotong Ma; Xiaokang Ji; Shaowei Sang; Sai Shao; Yuanyuan Zhao; Yuanyuan Xiang; Jifeng Li; Guangbin Wang; Ming Lv; Fuzhong Xue; Yifeng Du; Qinjian Sun
Journal:  Neurol Sci       Date:  2020-01-23       Impact factor: 3.307

Review 10.  Pathological Continuum From the Rise in Pulse Pressure to Impaired Neurovascular Coupling and Cognitive Decline.

Authors:  Olivia de Montgolfier; Nathalie Thorin-Trescases; Eric Thorin
Journal:  Am J Hypertens       Date:  2020-04-29       Impact factor: 2.689

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.